Technology
GREATER MONTREAL and the REGION oF LYON are joining forces
To give a boost to LSHT Companies
(Source: Montréal International)
(Source: Montréal International)
As part of the 'Entretiens Jacques Cartier', held this year in Lyon until November 23, Greater Montréal and the region of Lyon have signed a memorandum of understanding to provide enhanced support to Montréal and Lyon companies in the life sciences and health technologies (LSHT) industry so that they can gain larger share of the international market.
Montréal International and ADERLY“”the equivalent Lyon agency (Invest in Lyon), the Centre québécois d'innovation en biotechnologie (CQIB - The Life Sciences Incubator in Québec) in the Biotech City, Montréal InVivo and the Lyonbiopole competitive cluster have agreed to join forces to provide companies seeking opportunities to expand abroad with full immersion in the local ecosystem, including support, a personalized course of action and temporary office space.
Source: ADERLY/ Invest in Lyon
Source: Lyonbiopôle
Source: Montréal InVivo - CQIB - The Biotech City
- The LSHT industry in Greater Montréal :
* More than 40,000 jobs in over 600 organizations, accounting for 80% of LSHT jobs in Québec
* Ranked 7th among top 20 North American cities in terms of concentration of LSHT jobs
* 27,000 students in LSHT programs
* Top city for research partnerships in Canada: $958 million invested between 2011 and 2015
* Ranked 1st among North American cities for most competitive LSHT operating costs: 24% cost advantage
* More than 40,000 jobs in over 600 organizations, accounting for 80% of LSHT jobs in Québec
* Ranked 7th among top 20 North American cities in terms of concentration of LSHT jobs
* 27,000 students in LSHT programs
* Top city for research partnerships in Canada: $958 million invested between 2011 and 2015
* Ranked 1st among North American cities for most competitive LSHT operating costs: 24% cost advantage
- The LSHT industry in Lyon :
* Nearly 60,000 jobs and 11,200 biotech and health facilities in Lyon (Acoss-Urssaf 31-12-2014, Insee-Clap 31-12-2013 and Insee-REE 2014)
* Leading vaccine production centre in the world
* More than 1 billion euros invested in vaccines and diagnoses since 2005
* One of the highest concentration of university teaching hospitals in Europe
* More than 1,000 clinical trials conducted each year at HCLs (Lyon public hospitals)
* Lyonbiopole, leading health hub in France
Source : Montréal International
Ruby BIRD
http://www.portfolio.uspa24.com/
Yasmina BEDDOU
http://www.yasmina-beddou.uspa24.com/
* Nearly 60,000 jobs and 11,200 biotech and health facilities in Lyon (Acoss-Urssaf 31-12-2014, Insee-Clap 31-12-2013 and Insee-REE 2014)
* Leading vaccine production centre in the world
* More than 1 billion euros invested in vaccines and diagnoses since 2005
* One of the highest concentration of university teaching hospitals in Europe
* More than 1,000 clinical trials conducted each year at HCLs (Lyon public hospitals)
* Lyonbiopole, leading health hub in France
Source : Montréal International
Ruby BIRD
http://www.portfolio.uspa24.com/
Yasmina BEDDOU
http://www.yasmina-beddou.uspa24.com/
Liability for this article lies with the author, who also holds the copyright. Editorial content from USPA may be quoted on other websites as long as the quote comprises no more than 5% of the entire text, is marked as such and the source is named (via hyperlink).
